Both endocrine and chemotherapy can be utilized for breast cancer patients’ management, in multiple setting (i.e., primary systemic therapy, adjuvant, metastatic treatment). Health-related quality of life in breast cancer survivors can be significantly influenced by cognitive impairment, which has been related in several previously reported experiences to systemic therapies administration. However, although the growing body of literature, the impact of both chemo- and endocrine therapy on cognitive function is currently unclear, due to many confounding factors (i.e., multiple therapies, duration of therapy, comorbidity, age). The aim of the present review is to present an overview of the current literature concerning the possible influence of endocrine and systemic therapy on breast cancer patients’ cognitive impairment.

Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature / Meattini, Icro; Desideri, Isacco; Francolini, Giulio; Vannini, Agnese; Perna, Marco; Garlatti, Pietro; Grassi, Roberta; Livi, Lorenzo. - In: MEDICAL ONCOLOGY. - ISSN 1357-0560. - ELETTRONICO. - 34:(2017), pp. 0-0. [10.1007/s12032-017-0935-0]

Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature

MEATTINI, ICRO;DESIDERI, ISACCO;FRANCOLINI, GIULIO;VANNINI, AGNESE;PERNA, MARCO;GARLATTI, PIETRO;GRASSI, ROBERTA;LIVI, LORENZO
2017

Abstract

Both endocrine and chemotherapy can be utilized for breast cancer patients’ management, in multiple setting (i.e., primary systemic therapy, adjuvant, metastatic treatment). Health-related quality of life in breast cancer survivors can be significantly influenced by cognitive impairment, which has been related in several previously reported experiences to systemic therapies administration. However, although the growing body of literature, the impact of both chemo- and endocrine therapy on cognitive function is currently unclear, due to many confounding factors (i.e., multiple therapies, duration of therapy, comorbidity, age). The aim of the present review is to present an overview of the current literature concerning the possible influence of endocrine and systemic therapy on breast cancer patients’ cognitive impairment.
2017
34
0
0
Meattini, Icro; Desideri, Isacco; Francolini, Giulio; Vannini, Agnese; Perna, Marco; Garlatti, Pietro; Grassi, Roberta; Livi, Lorenzo
File in questo prodotto:
File Dimensione Formato  
Meattini et al_Med Oncol_2017_Cognitive Impairment.pdf

Accesso chiuso

Descrizione: Paper
Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 401.5 kB
Formato Adobe PDF
401.5 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1078748
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact